News

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

Feeling “off” turned into a critical situation within moments when Stacee suffered a ruptured brain aneurysm that led to a hemorrhagic stroke.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

We’re talking about how younger women and men can monitor for breast cancer and recent updates in screening guidelines.

This week during Breast Cancer Awareness Month, we’re talking about metastatic breast cancer and Saint Luke’s Koontz Center—the region’s only center dedicated and designed specifically for these patients.

An elementary school music teacher and jazz musician, 54-year-old Lisa was initially diagnosed with high blood pressure—the number one killer of women—in her early 30s. It is often called “the silent killer” because most who have it don’t experience any symptoms. Lisa was on blood pressure medication but had stopped taking it because she experienced side effects. She put off seeing her doctor about it for several months.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.

Reconnecting with a former high school classmate turned out to be a saving grace in Lori’s life.